Xu Huiqin

Xu Huiqin


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
SHSirui Hang
Sirui Hang
LXLiu Xu
Liu Xu
RMRuixue Ma
Ruixue Ma
XHXu Huiqin
Xu Huiqin
Xiaojuan ZhangXiaojuan Zhang
Xiaojuan Zhang
HCHe Chuanchuan
He Chuanchuan
As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH−) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.